Table 2.
Presenting symptom related variables censoring status and survival experience among COVID-19 patients (n=244)
| Variables | Censoring status | Total (%) | Median survival time (days) |
P-value | ||
|
| ||||||
| No of event (%) |
No of censored (%) |
|||||
| Presence of symptom | ||||||
| Asymptomatic | 11 (91.7) | 1 (8.3) | 12 (4.9) | 6 | 0.662 | |
| Symptomatic | 180 (77.6) | 52 (22.4) | 232 (95.1) | 8 | ||
| Fever | ||||||
| No | 118 (74.2) | 41 (25.8) | 159 (65.2) | 8 | 0.360 | |
| Yes | 73 (85.9) | 12 (14.1) | 85 (34.8) | 7 | ||
| Cough | ||||||
| No | 35 (74.5) | 12 (25.5) | 47 (19.3) | 8 | 0.465 | |
| Yes | 156 (79.2) | 41 (20.8) | 197 (80.7) | 8 | ||
| Cough with sputum | ||||||
| No | 102 (79.7) | 26 (20.3) | 128 (52.5) | 7 | 0.603 | |
| Yes | 89 (76.7) | 27 (23.3) | 116 (47.5) | 8 | ||
| Sore throat | ||||||
| No | 156 (76.5) | 48 (23.5) | 204 (83.6) | 8 | 0.887 | |
| Yes | 35 (87.5) | 5 (12.5) | 40 (16.4) | 8 | ||
| Chest pain | ||||||
| No | 121 (75.2) | 40 (24.8) | 161 (65.9) | 8 | 0.230 | |
| Yes | 70 (84.3) | 13 (15.7) | 83 (34.1) | 8 | ||
| Myalgia | ||||||
| No | 157 (77.3) | 46 (22.7) | 203 (83.2) | 8 | 0.193 | |
| Yes | 34 (82.9) | 7 (17.1) | 41 (16.8) | 6 | ||
| Arthralgia | ||||||
| No | 153 (78.1) | 43 (21.9) | 196 (80.3) | 8 | 0.482 | |
| Yes | 38 (79.2) | 10 (20.8) | 48 (19.7) | 6 | ||
| Fatigue | ||||||
| No | 102 (79.7) | 26 (20.3) | 128 (52.5) | 8 | 0.466 | |
| Yes | 89 (76.7) | 27 (23.3) | 116 (47.5) | 8 | ||
| SOB | ||||||
| No | 73 (83.9) | 14 (16.1) | 87 (35.7) | 6 | 0.034* | |
| Yes | 118 (75.2) | 39 (24.8) | 157 (64.3) | 8 | ||
| Headache | ||||||
| No | 143 (77.7) | 41 (22.3) | 184 (75.4) | 8 | 0.949 | |
| Yes | 48 (80.0) | 12 (20.0) | 60 (24.6) | 8 | ||
| Nausea/ vomiting | ||||||
| No | 176 (78.2) | 49 (21.8) | 225 (92.2) | 8 | 0.638 | |
| Yes | 15 (78.9) | 4 (21.1) | 19 (7.8) | 7 | ||
| Diarrhea | ||||||
| No | 182 (79.1) | 48 (20.9) | 230 (94.3) | 8 | 0.398 | |
| Yes | 9 (64.3) | 5 (35.7) | 14 (5.7) | 20 | ||